Procaps Group S.A.
Procaps Group S.A. (PROC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PROC · as of Jun 9, 2026
Key Statistics
Explore Procaps Group S.A. Data
proc stock data · financialsCompetitors & Peers
proc competitorsPROC
AUGX
GENE
GRAY
OPNT
OPTNAbout Procaps Group S.A.
Procaps Group S.A. established in Luxembourg in 1977, functions as a global pharmaceutical enterprise dedicated to the creation, production, and distribution of a broad spectrum of pharmaceutical sol…
what is procaps group s.a. · proc stock overview · procaps group s.a. company profile · who is procaps group s.a. ceo · proc NASDAQ · procaps group s.a. headquarters · procaps group s.a. business segments
About Stock Overview & Key Data
Procaps Group S.A. (PROC) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Dec 9, 2019. As of the latest trading session, PROC stock price is $1.01, with a market capitalization of $102.1M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Procaps Group S.A. (PROC) stock price is $1.01. The stock is traded on NASDAQ under the ticker symbol PROC. The 52-week range is $0.50 – $3.77.